Diagnostic anti-Insulin-like growth factor binding protein 1 (IGFBP-1) antibodies (anti-Insulin-like growth factor binding protein 1, anti-IGFBP-1) and diagnostic hapten-carrier conjugates BSA-Insulin-like growth factor binding protein 1 (IGFBP-1), OVA-Insulin-like growth factor binding protein 1 (IGFBP-1), KLH-Insulin-like growth factor binding protein 1 (IGFBP-1) antigens for Hormone disorders IGFBP-1 detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Genemedi produces core diagnostic ingredients for test of Hormone disorders (Pregnancy) and related syndrome. GeneMedi offers paired anti-Insulin-like growth factor binding protein 1 (IGFBP-1) antibodies (monoclonal antibody, mab) and Insulin-like growth factor binding protein 1 (IGFBP-1 antigens (Carrier-coupled antigen, immunogen, hapten-carrier conjugates, BSA-conjugated, OVA-conjugated, KLH-conjugated) for Hormone disorders (Pregnancy) rapid test kit of Insulin-like growth factor binding protein 1 (IGFBP-1) testing in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. The carrier-coupled antigens of small molecules can act as immunogens.Premature rupture of membranes (PROM) is essential to maintain the pregnancy. Various diagnosis method has been used to diagnose PROM. Insulin-like growth factor binding protein-1 (IGFBP-1) is present in an essentially higher concentration in amniotic fluid, than in serum, cervical mucous, urine and seminal plasma. IGFBP is present in high concentration in amniotic fluid.